139 related articles for article (PubMed ID: 3715061)
1. Therapeutic enhancement in mice by clinically relevant dose and fractionation schedules of cis-diamminedichloroplatinum (II) and irradiation.
Bartelink H; Kallman RF; Rapacchietta D; Hart GA
Radiother Oncol; 1986 May; 6(1):61-74. PubMed ID: 3715061
[TBL] [Abstract][Full Text] [Related]
2. Effects of fractionated schedules of irradiation combined with cis-diamminedichloroplatinum II on the SCCVII/St tumor and normal tissues of the C3H/KM mouse.
Tanabe M; Godat D; Kallman RF
Int J Radiat Oncol Biol Phys; 1987 Oct; 13(10):1523-32. PubMed ID: 3624028
[TBL] [Abstract][Full Text] [Related]
3. Schedule-dependent therapeutic gain from the combination of fractionated irradiation plus c-DDP and 5-FU or plus c-DDP and cyclophosphamide in C3H/Km mouse model systems.
Kallman RF; Rapacchietta D; Zaghloul MS
Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):227-32. PubMed ID: 1991683
[TBL] [Abstract][Full Text] [Related]
4. Schedule-dependent therapeutic gain from the combination of fractionated irradiation and cis-diamminedichloroplatinum (II) in C3H/Km mouse model systems.
Kanazawa H; Rapacchietta D; Kallman RF
Cancer Res; 1988 Jun; 48(11):3158-64. PubMed ID: 2966671
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 modulatory effect on the action of chemotherapeutic drugs and localized irradiation of the lip, duodenum, and tumor.
Zaghloul MS; Dorie MJ; Kallman RF
Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):417-25. PubMed ID: 8514539
[TBL] [Abstract][Full Text] [Related]
6. The effect of treatment in fractionated schedules with the combination of X-irradiation and six cytotoxic drugs on the RIF-1 tumor and normal mouse skin.
Lelieveld P; Scoles MA; Brown JM; Kallman RF
Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):111-21. PubMed ID: 4038500
[TBL] [Abstract][Full Text] [Related]
7. Lack of differential radiosensitization of hypoxic cells in a mouse tumor at low radiation doses per fraction by cisplatin.
Sun JR; Brown JM
Radiat Res; 1993 Feb; 133(2):252-6. PubMed ID: 8438067
[TBL] [Abstract][Full Text] [Related]
8. Protection by WR-2721 against radiation plus cis-diamminedichloroplatinum II caused injury to colonic epithelium in mice.
Ito H; Komaki R; Milas L
Int J Radiat Oncol Biol Phys; 1994 Mar; 28(4):899-903. PubMed ID: 8138443
[TBL] [Abstract][Full Text] [Related]
9. Interaction of hyperthermia and cis-diamminedichloroplatinum(II) alone or combined with radiation in a C3H mammary carcinoma in vivo.
Overgaard J; Radacic MM; Grau C
Cancer Res; 1991 Jan; 51(2):707-11. PubMed ID: 1985787
[TBL] [Abstract][Full Text] [Related]
10. The effects of cis-diamminedichloroplatinum (II) and radiation on the proliferation kinetics of mouse duodenal crypt cells and on a partially synchronized crypt cell population.
Dewit L; Oussoren Y; Bartelink H
Int J Radiat Oncol Biol Phys; 1986 Nov; 12(11):1977-85. PubMed ID: 2945805
[TBL] [Abstract][Full Text] [Related]
11. The importance of schedule and drug dose intensity in combinations of modalities.
Kallman RF
Int J Radiat Oncol Biol Phys; 1994 Feb; 28(3):761-71. PubMed ID: 8113123
[TBL] [Abstract][Full Text] [Related]
12. Modification by cis-diamminedichloroplatinum (II) of the radiation dose-response curve for intestinal crypt cells in mice.
Dewit L; Oussoren Y; Hart G
Radiat Res; 1987 Sep; 111(3):445-56. PubMed ID: 3659279
[TBL] [Abstract][Full Text] [Related]
13. Dose and time effects of cis-diamminedichloroplatinum(II) and radiation on mouse duodenal crypts.
Dewit L; Oussoren Y; Bartelink H
Radiother Oncol; 1985 Dec; 4(4):363-71. PubMed ID: 4081125
[TBL] [Abstract][Full Text] [Related]
14. The response of previously irradiated skin to combinations of fractionated X radiation, hyperthermia, and cis-diamminedichloroplatinum.
Baker DG; Sager H; Constable W; Goodchild N
Radiat Res; 1984 Apr; 98(1):176-81. PubMed ID: 6538984
[TBL] [Abstract][Full Text] [Related]
15. The effect of UCN-01 (7-hydroxystaurosporine), a potent inhibitor of protein kinase C, on fractionated radiotherapy or daily chemotherapy of a murine fibrosarcoma.
Tsuchida E; Urano M
Int J Radiat Oncol Biol Phys; 1997 Dec; 39(5):1153-61. PubMed ID: 9392558
[TBL] [Abstract][Full Text] [Related]
16. Response of previously irradiated skin to combinations of x radiation, hyperthermia, and cis-diamminedichloroplatinum.
Baker D; Sager H; Constable W; Goodchild N
Cancer Invest; 1984; 2(1):15-9. PubMed ID: 6538454
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the enhancement of tumor responses to fractionated irradiation by SR 4233 (tirapazamine) and by nicotinamide with carbogen.
Dorie MJ; Menke D; Brown JM
Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):145-50. PubMed ID: 8270435
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 1 increases thymidine labeling index of normal tissues of mice but not the tumor.
Zaghloul MS; Dorie MJ; Kallman RF
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):805-11. PubMed ID: 8040027
[TBL] [Abstract][Full Text] [Related]
19. The influence of cisplatin on the response of mouse kidneys to multifraction irradiation.
Stewart FA; Oussoren Y; Bartelink H
Radiother Oncol; 1989 May; 15(1):93-102. PubMed ID: 2748946
[TBL] [Abstract][Full Text] [Related]
20. The effect of cis-diamminedichloroplatinum(II) on radiation damage in mouse rectum after fractionated irradiation.
Dewit L; Oussoren Y; Bartelink H; Thames HD
Radiother Oncol; 1989 Oct; 16(2):121-8. PubMed ID: 2531905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
